Finance

Beta
Lists
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
၁၀.၁၃ US$
+၂.၇၄%
(+၀.၂၇) 1D
၉.၉၃ US$
-၁.၉၇% (-၀.၂၀)
After hours
Closed: ဇွန် ၅, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
၉.၈၆ US$
High
၁၀.၂၀ US$
Low
၉.၇၇ US$
Mkt. cap
၈၀.၇၉ ကုဋေ
Avg. vol.
၁.၄၁ သန်း
Volume
၁.၁၆ သန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၄.၇၁ US$
EPS
-၂.၁၁ US$
Beta
၀.၅၀
Shares outstanding
၇.၉၈ ကုဋေ
No. of employees
၃၇၁
Open
၉.၈၆ US$
High
၁၀.၂၀ US$
Low
၉.၇၇ US$
Mkt. cap
၈၀.၇၉ ကုဋေ
Avg. vol.
၁.၄၁ သန်း
Volume
၁.၁၆ သန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၄.၇၁ US$
EPS
-၂.၁၁ US$
Beta
၀.၅၀
Shares outstanding
၇.၉၈ ကုဋေ
No. of employees
၃၇၁
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current ၁၀.၁၃ US$
၂၈.၀၀ US$ (+၁၇၆.၄၁%)
Average
၂၄.၂၅ US$ (+၁၃၉.၃၉%)
Lowest
၁၈.၀၀ US$ (+၇၇.၆၉%)
News stories
From sources across the web
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၅၁ မိနစ်
Goldman Sachs: Signs of market exuberance are rising, but fall short of prior bubbles (SP500:)
TechStock²
TechStock²
·
ပြီးခဲ့သည့် ၉ မိနစ်
Warner Bros. Discovery Move on Watch for Monday as Market Eyes Next Step
Axios
Axios
·
ပြီးခဲ့သည့် ၁ ရက်
Chips sector bloodbath drags Nasdaq down 4.2%
About Phathom Pharmaceuticals Inc
CEO-
Employees၃၇၁
Founded၂၀၁၈
HeadquartersFlorham Park, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Last report
၂၀၂၆ ဧ ၃၀
Fiscal period
Q1 2026
EPS / Est. (USD)
-၀.၁၈ US$ / -၀.၂၀ US$
+၁၁.၀၄%beat
Revenue / Est. (USD)
၅.၈၃ ကုဋေ / ၅.၇၄ ကုဋေ
+၁.၆၄%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၃.၉၅ ကုဋေ
၄.၉၅ ကုဋေ
၅.၇၆ ကုဋေ
၅.၈၃ ကုဋေ
Cost of goods sold
၅.၀၄ သန်း
၆.၁၉ သန်း
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
Cost of revenue
၅.၀၄ သန်း
၆.၁၉ သန်း
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
Research and development expenses
၉.၀၈ သန်း
၇.၀၃ သန်း
၇.၄၉ သန်း
၇.၇၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၅၃ ကုဋေ
၅.၁၆ ကုဋေ
၄.၈၄ ကုဋေ
၅.၄၀ ကုဋေ
Operating expense
၉.၄၄ ကုဋေ
၅.၈၆ ကုဋေ
၅.၅၉ ကုဋေ
၆.၁၈ ကုဋေ
Total operating expenses
၉.၉၄ ကုဋေ
၆.၄၈ ကုဋေ
၆.၃၅ ကုဋေ
၇.၃၈ ကုဋေ
Operating income
-၅.၉၉ ကုဋေ
-၁.၅၃ ကုဋေ
-၅.၉၃ သန်း
-၁.၅၅ ကုဋေ
Other non operating income
-၁.၅၅ သိန်း
-၇.၀၀ ထောင်
-၅.၀၀ ထောင်
-၈.၃၁ သိန်း
EBT including unusual items
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
EBT excluding unusual items
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
Net profit margin
-၁၉၁.၉၁%
-၆၀.၅၅%
-၃၆.၇၃%
-၅၂.၀၉%
Earnings per share
-၀.၇၉
-၀.၁၅
-၀.၀၈
-၀.၁၈
Interest and investment income
၁.၇၉ သန်း
၁.၄၁ သန်း
၁.၂၀ သန်း
၁.၇၄ သန်း
Interest expense
-၁.၇၅ ကုဋေ
-၁.၆၁ ကုဋေ
-၁.၆၄ ကုဋေ
-၁.၅၈ ကုဋေ
Net interest expenses
-၁.၅၇ ကုဋေ
-၁.၄၇ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၄၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၉၈ ကုဋေ
-၁.၅၁ ကုဋေ
-၅.၈၀ သန်း
-၁.၅၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more